πŸ”† πŸ“– βž• πŸ‘€

Statutory Instruments

2023 No. 239

National Health Service, England And Wales

National Health Service, Scotland

Health And Personal Social Services, Northern Ireland

The Branded Health Service Medicines (Costs) (Amendment) Regulations 2023

Made

28th February 2023

Laid before Parliament

2nd March 2023

Coming into force

1st April 2023

The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 263(1), 264(3), 266(1) and (4A) and 272(7) and (8) of the National Health Service Act 2006( 1 ).

The Secretary of State has consulted in accordance with section 263(1) and (1A) of that Act.

Citation, commencement and extent

1. β€”(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 and come into force on 1st April 2023.

(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.

Amendment of regulation 3 of the Branded Health Service Medicines (Costs) Regulations 2018

2. β€”(1)Regulation 3 (Payment scheme) of The Branded Health Service Medicines (Costs) Regulations 2018( 2 ) is amended as follows.

(2) In paragraph (1), for the table substituteβ€”

β€œ Table

Applicable Period Payment Percentage
1st April 2023 to the end of 2023 27.5%
2024 and any subsequent calendar year 27.5% ” .

(3) In paragraph (1B)β€”

(a) for β€œ1st July 2022 to the end of 2022” substitute β€œ1st April 2023 to the end of 2023” ,

(b) for β€œ17.7%” substitute β€œ28.6%” , and

(c) for β€œ14.3%” substitute β€œ27.5%” .

(4) In paragraph (1C)β€”

(a) for β€œ1st July 2022 to the end of 2022” substitute β€œ1st April 2023 to the end of 2023” ,

(b) in sub-paragraph (a)β€”

(i) for β€œ1st January 2022” substitute β€œ1st January 2023” , and

(ii) for β€œ30th June 2022” substitute β€œ31st March 2023” , and

(c) in sub-paragraph (b), for β€œ10.9%” substitute β€œ24.4%” .

Signed by the authority of the Secretary of State for Health and Social Care

Will Quince

Minister of State,

Department of Health and Social Care

28th February 2023

( 1 )

2006 c. 41 ; section 263 was amended by the Health Service Medical Supplies (Costs) Act (c. 23) (β€œ the 2017 Act ”), section 5 and 10(5). Section 266 was amended by the 2017 Act, section 6(5) to (9) and 7(6). See section 275(1) of the National Health Service Act 2006 for definition of β€œregulations” that are relevant to the powers being exercised.

( 2 )

S.I 2018/345 ; relevant amending instruments are S.I. 2018/1255 , S.I. 2020/258 and S.I. 2022/593 .

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
The Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 (2023/239)

Displaying information

Status of this instrument

footnotecommentarytransitional and savingsin force statusrelated provisionsgeo extentinsert/omitsource countin force adj
Defined TermSection/ArticleIDScope of Application
This instrument is derived from the version at www.legislation.gov.uk. To see a list of all amendments (including any to be made) check the resources page for this instrument on their website. Note, the status of this instrument is given above.
This instrument is derived from the version at www.legislation.gov.uk. To see original commencement information, check the resources page associated with this instrument. n.b. commencement information for marked amendments is embedded in the relevant footnote.

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.